Gerald Manorek

940 total citations
18 papers, 739 citations indexed

About

Gerald Manorek is a scholar working on Oncology, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, Gerald Manorek has authored 18 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Nutrition and Dietetics. Recurrent topics in Gerald Manorek's work include Trace Elements in Health (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and Barrier Structure and Function Studies (6 papers). Gerald Manorek is often cited by papers focused on Trace Elements in Health (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and Barrier Structure and Function Studies (6 papers). Gerald Manorek collaborates with scholars based in United States, Switzerland and Netherlands. Gerald Manorek's co-authors include Stephen B. Howell, Alison K. Holzer, Xinjian Lin, Xiying Shang, Goli Samimi, Edwin Alvarez, Xiaoqin Yuan, Charles C. Berry, Gerrit Los and Lawrence H. Cheung and has published in prestigious journals such as Nature Genetics, PLoS ONE and Cancer Research.

In The Last Decade

Gerald Manorek

18 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerald Manorek United States	13	325	321	151	136	105	18	739
Xuejia Kang United States	14	378 1.2×	207 0.6×	35 0.2×	115 0.8×	28 0.3×	28	899
Arijit Bhowmik India	11	381 1.2×	147 0.5×	50 0.3×	108 0.8×	9 0.1×	27	686
Marta Martins Portugal	17	438 1.3×	162 0.5×	64 0.4×	58 0.4×	10 0.1×	33	889
Sufang Zhou China	20	690 2.1×	240 0.7×	40 0.3×	153 1.1×	10 0.1×	69	1.2k
Naoki Umemura Japan	17	324 1.0×	241 0.8×	59 0.4×	85 0.6×	12 0.1×	40	931
Jing Hou China	18	710 2.2×	294 0.9×	18 0.1×	433 3.2×	18 0.2×	55	1.1k
Benny Zhitomirsky Israel	7	491 1.5×	200 0.6×	10 0.1×	111 0.8×	19 0.2×	7	860
Jin Gao China	13	352 1.1×	224 0.7×	6 0.0×	107 0.8×	65 0.6×	39	702
Hyang‐Hwa Ryu South Korea	15	277 0.9×	106 0.3×	10 0.1×	84 0.6×	23 0.2×	27	699

Countries citing papers authored by Gerald Manorek

Since Specialization

Citations

This map shows the geographic impact of Gerald Manorek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Manorek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Manorek more than expected).

Fields of papers citing papers by Gerald Manorek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Manorek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Manorek. The network helps show where Gerald Manorek may publish in the future.

Co-authorship network of co-authors of Gerald Manorek

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Manorek. A scholar is included among the top collaborators of Gerald Manorek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Manorek. Gerald Manorek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Shang, Xiying, et al.. (2014). Integrin alphaV modulates the cellular pharmacology of copper and cisplatin by regulating expression of the influx transporter CTR1. Oncoscience. 1(3). 185–195. 4 indexed citations

Lin, Xinjian, Xiying Shang, Gerald Manorek, & Stephen B. Howell. (2013). Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4. PLoS ONE. 8(6). e67496–e67496. 95 indexed citations

Safaei, Roohangiz, et al.. (2013). The role of metal binding and phosphorylation domains in the regulation of cisplatin-induced trafficking of ATP7B. Metallomics. 5(8). 964–964. 13 indexed citations

Lin, Xinjian, Xiying Shang, Gerald Manorek, & Stephen H. Howell. (2013). Abstract 211: Control of integrin expression and signaling by claudin-3 and claudin-4 in ovarian cancer.. Cancer Research. 73(8_Supplement). 211–211. 2 indexed citations

Shang, Xiying, Xinjian Lin, Gerald Manorek, & Stephen B. Howell. (2012). Claudin-3 and Claudin-4 Regulate Sensitivity to Cisplatin by Controlling Expression of the Copper and Cisplatin Influx Transporter CTR1. Molecular Pharmacology. 83(1). 85–94. 39 indexed citations

Abada, Paolo, et al.. (2012). Sec61β Controls Sensitivity to Platinum-Containing Chemotherapeutic Agents through Modulation of the Copper-Transporting ATPase ATP7A. Molecular Pharmacology. 82(3). 510–520. 14 indexed citations

Shang, Xiying, Xinjian Lin, Edwin Alvarez, Gerald Manorek, & Stephen B. Howell. (2012). Tight Junction Proteins Claudin-3 and Claudin-4 Control Tumor Growth and Metastases. Neoplasia. 14(10). 974–IN22. 85 indexed citations

Yuan, Xiaoqin, Xinjian Lin, Gerald Manorek, & Stephen B. Howell. (2011). Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency. BMC Cancer. 11(1). 61–61. 23 indexed citations

Kanatani, Isao, Xinjian Lin, Xiaoqin Yuan, et al.. (2011). Targeting granzyme B to tumor cells using a yoked human chorionic gonadotropin. Cancer Chemotherapy and Pharmacology. 68(4). 979–990. 10 indexed citations

10.

Yuan, Xiaoqin, Xinjian Lin, Gerald Manorek, et al.. (2009). Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors. Molecular Cancer Therapeutics. 8(7). 1906–1915. 48 indexed citations

11.

Kong, Seong Deok, et al.. (2007). Acidic Hydrolysis of N-Ethoxybenzylimidazoles (NEBIs): Potential Applications as pH-Sensitive Linkers for Drug Delivery. Bioconjugate Chemistry. 18(2). 293–296. 34 indexed citations

12.

Samimi, Goli, et al.. (2006). Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin. Cancer Chemotherapy and Pharmacology. 59(3). 301–312. 22 indexed citations

13.

Cheng, Timothy, Gerald Manorek, Goli Samimi, et al.. (2006). Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells. Cancer Chemotherapy and Pharmacology. 58(3). 384–395. 38 indexed citations

14.

Holzer, Alison K., Gerald Manorek, & Stephen B. Howell. (2006). Contribution of the Major Copper Influx Transporter CTR1 to the Cellular Accumulation of Cisplatin, Carboplatin, and Oxaliplatin. Molecular Pharmacology. 70(4). 1390–1394. 250 indexed citations

15.

Samimi, Goli, et al.. (2004). cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance. Cancer Chemotherapy and Pharmacology. 55(1). 1–11. 43 indexed citations

16.

Los, Gerrit, et al.. (2002). Identification of Transdominant-Negative Genetic Suppressor Elements Derived from hMSH2 That Mediate Resistance to 6-Thioguanine. Molecular Pharmacology. 62(5). 1198–1206. 4 indexed citations

17.

Los, Gerrit, et al.. (2001). Using mRNA expression profiling to determine anticancer drug efficacy. Cytometry. 47(1). 66–71. 14 indexed citations

18.

Yang, Fei, Gerald Manorek, & Gerrit Los. (2001). Unique expression patterns for paclitaxel, doxorubicin and cisplatin in breast carcinoma cells. Nature Genetics. 27(S4). 70–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact